Business Description
Supernus Pharmaceuticals is a US-based company focused on developing and selling medicines that treat brain and nervous system conditions. Its current lineup includes treatments for ADHD, Parkinson's disease, epilepsy, cervical dystonia, and chronic sialorrhea, sold through wholesalers, specialty pharmacies, and distributors. The company also has several drugs in clinical trials targeting epilepsy, treatment-resistant depression, and ADHD. Founded in 2005 and headquartered in Rockville, Maryland, Supernus continues to grow its portfolio through internal research and external development partnerships.